Levodopa with carbidopa diminishes glycogen concentration, glycogen synthase activity, and insulin-stimulated glucose transport in rat skeletal muscle

Keyphrases

• Levodopa 100%
• Insulin 100%
• Glucose Transport 100%
• Glycogen Content 100%
• Rat Skeletal muscle 100%
• Glycogen Synthase 100%
• Carbidopa 100%
• Levodopa-carbidopa 100%
• Patients with Parkinson's Disease 33%
• Insulin Resistance 22%
• Propranolol 22%
• Skeletal muscle 22%
• Tyrosine Phosphorylation 22%
• Insulin Receptor Substrate 1 (IRS1) 22%
• Twice Daily 11%
• High Prevalence 11%
• Akt Phosphorylation 11%
• Insulin Action 11%
• Oral Glucose Tolerance Test 11%
• Glycogen 11%
• Adrenergic alpha-antagonists 11%
• Glycogen Accumulation 11%
• Isolated muscle 11%
• Drug-treated 11%
• In Vivo Dose 11%

Neuroscience

• Carbidopa/Levodopa 100%
• Glucose Transport 100%
• Skeletal Muscle 100%
• Glycogen Synthase 100%
• Parkinson's Disease 27%
• Insulin Receptor 18%
• Protein Phosphorylation 18%
• Propranolol 18%
• In Vivo 9%
• Cyclic Adenosine Monophosphate 9%
• Adrenergic Antagonist 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Carbidopa Plus Levodopa 100%
• Glycogen Synthase 100%
• Parkinson's Disease 27%
• Insulin Resistance 18%
• Propranolol 18%
• Insulin Receptor Substrate 1 18%
• Prevalence 9%
• Adrenergic Receptor Blocking Agent 9%